Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Integral Diagnostics Ltd. ( (AU:IDX) ).
Integral Diagnostics Limited announced that all resolutions at its Annual General Meeting were passed, reflecting strong shareholder support. The successful resolutions, including the election of directors and approval of financial assistance, indicate stability and continued confidence in the company’s strategic direction.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company focuses on delivering quality patient care and service through a unique medical leadership model.
Average Trading Volume: 1,249,543
Technical Sentiment Signal: Sell
Current Market Cap: A$954.7M
See more insights into IDX stock on TipRanks’ Stock Analysis page.